| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |